Goldman Sachs Reaffirms CIGNA Buy Rating And $45 PT

Following meetings with CIGNA Corporation CI management, Goldman Sachs said that it has reaffirmed its CL-Buy on CIGNA and maintains its 2010-2012 EPS and $45 price target. CIGNA Corporation closed Wednesday at $36.93.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: Analyst RatingsCIGNA CorporationGoldman SachsHealth CareManaged Health Care
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!